Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine-Reference-Cited by-同舟云学术

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

Published:2018-02-03 Issue:2 Volume:67 Page:193-201
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Brooks Kristina M¹,George Jomy M¹,Pau Alice K²,Rupert Adam³,Mehaffy Carolina⁴,De Prithwiraj⁴,Dobos Karen M⁴,Kellogg Anela⁵,McLaughlin Mary⁶,McManus Maryellen⁷,Alfaro Raul M¹,Hadigan Colleen⁶,Kovacs Joseph A⁷,Kumar Parag¹

Affiliation:

1. Clinical Pharmacokinetics Research Unit, Pharmacy Department, Clinical Center, National Institutes of Health (NIH), Frederick, Maryland

2. Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Frederick, Maryland

3. AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland

4. Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins

5. Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Bethesda, Maryland

6. Clinical Research Section, NIAID, Bethesda, Maryland

7. Critical Care Medicine Department, Clinical Center, NIH, Bethesda, Maryland

Funder

National Cancer Institute, NIH

Centers for Disease Control and Prevention Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/2/193/25103169/ciy082.pdf

Reference38 articles.